Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep versus moderate neuromuscular block in morbidly obese patients undergoing laparoscopic bariatric surgery
NL-OMON44073Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of rocuronium and Sugammadex in obesity (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Surgical conditions. Started Sep 2015; status: active, not recruiting.
02
Drugs
rocuroniumSugammadex
03
Conditions
obesity
Beyond the preview
Go deeper on NL-OMON44073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44073.